NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy, Immunity, vol.28, issue.4, pp.571-80, 2008. ,
DOI : 10.1016/j.immuni.2008.02.016
Accelerated tumor growth in mice deficient in DNAM-1 receptor, The Journal of Experimental Medicine, vol.92, issue.13, pp.2959-64, 2008. ,
DOI : 10.1038/bjc.1950.36
The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells, Cancer Research, vol.67, issue.18, pp.8444-8453, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4230
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype, Blood, vol.113, issue.15, pp.3503-3514, 2009. ,
DOI : 10.1182/blood-2008-08-173914
Senescence of Activated Stellate Cells Limits Liver Fibrosis, Cell, vol.134, issue.4, pp.657-67, 2008. ,
DOI : 10.1016/j.cell.2008.06.049
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development, Nature, vol.278, issue.7374, pp.547-51, 2011. ,
DOI : 10.1038/nature10599
Targeting the dynamic HSP90 complex in cancer, Nature Reviews Cancer, vol.114, issue.8, pp.537-494385, 2009. ,
DOI : 10.1038/nrc2887
Glycogen synthase kinase 3?? (GSK3??) in tumorigenesis and cancer chemotherapy, Cancer Letters, vol.273, issue.2, pp.194-200, 2009. ,
DOI : 10.1016/j.canlet.2008.05.045
Inhibition of Glycogen Synthase Kinase-3 Increases NKG2D Ligand MICA Expression and Sensitivity to NK Cell-Mediated Cytotoxicity in Multiple Myeloma Cells: Role of STAT3, The Journal of Immunology, vol.190, issue.12, pp.6662-72, 2013. ,
DOI : 10.4049/jimmunol.1201426
URL : https://hal.archives-ouvertes.fr/pasteur-01054147